The President’s plan, which is expected to reduce healthcare spending by $2 trillion over the next 10 years, raises legal concerns regarding compliance with U.S. antitrust laws for companies that collaborate to hold down pricing.
Current antitrust laws prohibit the establishment of maximum pricing agreements, in addition to minimum ones. The Federal Trade Commission also recently challenged a proposal by the American Medical Association that would allow physicians to collectively negotiate payment rates with insurers, saying that the collective action would constitute price-fixing.
The administration has not offered companies that participate in the program protection from antitrust laws.
Read the New York Times’ report on healthcare antitrust concerns.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
